Ribozyme inhibitors: deoxyguanosine and dideoxyguanosine are competitive inhibitors of self-splicing of the Tetrahymena ribosomal ribonucleic acid precursor.
The intervening sequence (IVS) of the Tetrahymena rRNA precursor catalyzes its own splicing. During splicing the 3'-hydroxyl of guanosine is ligated to the 5' terminus of the IVS. One catalytic strategy of the IVS RNA is to specifically bind its guanosine substrate. Deoxyguanosine (dG) and dideoxyguanosine (ddG) are found to be competitive inhibitors of self-splicing. Comparison of the kinetic parameters (Ki = 1.1 mM for dG; Ki = 5.4 mM for ddG; Km = 0.032 mM for guanosine) indicates that the ribose hydroxyls are necessary for optimal binding of guanosine to the RNA. dG is not a substrate for the reaction even at very high concentrations. Thus, in addition to aiding in binding, the 2'-hydroxyl is necessary for reaction of the 3'-hydroxyl. A second catalytic strategy of the IVS RNA is to enhance the reactivity of specific bonds. For example, the phosphodiester bond at the 3' splice site is extremely labile to hydrolysis. We find that dG and ddG, as well as 2'-O-methylguanosine and 3'-O-methylguanosine, reduce hydrolysis at the 3' splice site. These data are consistent with an RNA structure that brings the 5' and 3' splice sites proximal to the guanosine binding site.
D000818:Animals; D001483:Base Sequence; D001667:Binding, Competitive; D003849:Deoxyguanosine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D015224:Dideoxynucleosides; D007700:Kinetics; D009694:Nucleic Acid Precursors / Q000235:genetics*; D012322:RNA Precursors; D012326:RNA Splicing / Q000187:drug effects*; D012335:RNA, Ribosomal / Q000235:genetics*; D013768:Tetrahymena / Q000187:drug effects / Q000235:genetics*
D015224:Dideoxynucleosides; D009694:Nucleic Acid Precursors; D012322:RNA Precursors; D012335:RNA, Ribosomal; C050220:2',3'-dideoxyguanosine; D003849:Deoxyguanosine